NCT02161991View on ClinicalTrials.gov

Aprepitant for Chemotherapy Induced Nausea and Vomiting in Chinese Advanced Non-small Cell Lung Cancers

PHASE3CompletedINTERVENTIONAL
Enrollment

244

Participants

Timeline

Start Date

February 1, 2014

Primary Completion Date

February 1, 2017

Study Completion Date

January 31, 2018

Conditions
Carcinoma, Non-small Cell Lung
Interventions
DRUG

Aprepitant

aprepitant should be give when patients receive platinum based chemotherapy, 125mg for day1, 80mg for day2 and day3.

DRUG

placebo

placebo should be give when patients receive platinum based chemotherapy, 125mg for day1, 80mg for day2 and day3.

Trial Locations (1)

Unknown

Hunan Cancer hospital, Changsha

All Listed Sponsors
lead

Hunan Province Tumor Hospital

OTHER

NCT02161991 - Aprepitant for Chemotherapy Induced Nausea and Vomiting in Chinese Advanced Non-small Cell Lung Cancers | Biotech Hunter | Biotech Hunter